SCHEMBL3366948

SCHEMBL3366948

N#Cc1cc(Oc2ccc(NC(=O)Nc3ccc4c(c3)C(F)(F)OC(F)(F)O4)c(F)c2)ccn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 16/20 0.48
BRAF P15056 12/20 0.48
MAPK14 Q16539 3/20 0.43
RIPK2 O43353 2/20 0.43
KIT P10721 2/20 0.43
FLT1 P17948 2/20 0.43
ABCB11 O95342 1/20 0.43
ABL1 P00519 1/20 0.43
RAF1 P04049 1/20 0.43
NR3C1 P04150 1/20 0.43
RET P07949 1/20 0.43
HTR1A P08908 1/20 0.43
PDGFRB P09619 1/20 0.43
ADORA3 P0DMS8 1/20 0.43
CHRM1 P11229 1/20 0.43
BCR P11274 1/20 0.43
FGFR1 P11362 1/20 0.43
RARG P13631 1/20 0.43
PDGFRA P16234 1/20 0.43
MAOA P21397 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6473528 0.92 KDR (0.47) KDRBRAFMAPK14RIPK2KIT
SCHEMBL3366914 0.91 KDR (0.56) KDRBRAFMAPK14RIPK2KIT
SCHEMBL13363770 0.91 KDR (0.44) KDRBRAFKITTEK
SCHEMBL13363759 0.91 KDR (0.53) KDRBRAFMAPK14RIPK2KIT
SCHEMBL13363778 0.91 KDR (0.47) KDRBRAFKITRAF1
SCHEMBL13799389 0.90 KDR (0.46) KDRBRAFMAPK14RIPK2KIT
SCHEMBL1379400 0.90 KDR (0.46) KDRBRAFKITRAF1
SCHEMBL13790462 0.90 KDR (0.56) KDRBRAFMAPK14RIPK2KIT
SCHEMBL13790463 0.90 KDR (0.44) KDRBRAFMAPK14KITPDGFRA
SCHEMBL13363760 0.89 KDR (0.46) KDRBRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599467-B1 NOVEL CYANOPYRIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISORDERS BAYER HEALTHCARE LLC (US) 2010-05-19 EP disclosed
EP-1599467-B1 NOVEL CYANOPYRIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISORDERS BAYER HEALTHCARE LLC (US) 2010-05-19 EP disclosed
US-7557129-B2 Cyanopyridine derivatives useful in the treatment of cancer and other disorders BAYER HEALTHCARE LLC (US) 2009-07-07 US disclosed
US-7557129-B2 Cyanopyridine derivatives useful in the treatment of cancer and other disorders BAYER HEALTHCARE LLC (US) 2009-07-07 US disclosed
EP-1599467-A1 NOVEL CYANOPYRIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISORDERS Bayer Pharmaceuticals Corporation (US) 2005-11-30 EP disclosed
WO-2004078747-A1 NOVEL CYANOPYRIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2004-09-16 WO disclosed